The current round has an investment commitment of up to €3 million, which includes the participation of the founding partners. The €7 million will make it...
Ability Pharma is working on a drug capable of inducing cancer cell death through autophagy. ABTL0812 has demonstrated clinical efficacy in a Phase II clinical trial...